Essential role of TOSO/FAIM3 in intestinal IgM reverse transcytosis.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
16 11 2021
Historique:
received: 19 05 2020
revised: 17 05 2021
accepted: 26 10 2021
entrez: 17 11 2021
pubmed: 18 11 2021
medline: 15 2 2022
Statut: ppublish

Résumé

Secretory immunoglobulin A (SIgA) can travel to and from the lumen and transport antigen to subepithelial cells. However, IgM can also multimerize into functional secretory component-bound immunoglobulin. While it is already known that both SIgA and SIgM undergo transcytosis to be secreted at the mucosal surface, only SIgA has been shown to perform retrotranscytosis through microfold cells (M cells) of the Peyer's patch. Here, we investigate whether SIgM could also be taken up by M cells via retrotranscytosis. This transport involves FcμR binding at the apical membrane of M cells. We then demonstrate that SIgM can be exploited by SIgM-p24 (HIV-capsid protein) complexes during immunization in the nasal- or gut-associated lymphoid tissue (NALT or GALT), conferring efficient immune responses against p24. Our data demonstrate a mucosal function of SIgM, which could play a role in the regulation of mucosal immunity.

Identifiants

pubmed: 34788614
pii: S2211-1247(21)01484-4
doi: 10.1016/j.celrep.2021.110006
pii:
doi:

Substances chimiques

Apoptosis Regulatory Proteins 0
Faim protein, mouse 0
Fcmr protein, mouse 0
Immunoglobulin A, Secretory 0
Immunoglobulin M 0
Membrane Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

110006

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Auteurs

Nicolas Rochereau (N)

Centre International de Recherche en Infectiologie (CIRI), Team GIMAP, Université de Lyon, Université Claude Bernard Lyon 1, INSERM, U1111, CNRS, UMR530, CIC 1408 Vaccinology, 42023 Saint-Etienne, France.

Eva Michaud (E)

Centre International de Recherche en Infectiologie (CIRI), Team GIMAP, Université de Lyon, Université Claude Bernard Lyon 1, INSERM, U1111, CNRS, UMR530, CIC 1408 Vaccinology, 42023 Saint-Etienne, France.

Louis Waeckel (L)

Centre International de Recherche en Infectiologie (CIRI), Team GIMAP, Université de Lyon, Université Claude Bernard Lyon 1, INSERM, U1111, CNRS, UMR530, CIC 1408 Vaccinology, 42023 Saint-Etienne, France.

Martin Killian (M)

Centre International de Recherche en Infectiologie (CIRI), Team GIMAP, Université de Lyon, Université Claude Bernard Lyon 1, INSERM, U1111, CNRS, UMR530, CIC 1408 Vaccinology, 42023 Saint-Etienne, France.

Rémi Gayet (R)

Centre International de Recherche en Infectiologie (CIRI), Team GIMAP, Université de Lyon, Université Claude Bernard Lyon 1, INSERM, U1111, CNRS, UMR530, CIC 1408 Vaccinology, 42023 Saint-Etienne, France.

Roman Goguyer-Deschaumes (R)

Centre International de Recherche en Infectiologie (CIRI), Team GIMAP, Université de Lyon, Université Claude Bernard Lyon 1, INSERM, U1111, CNRS, UMR530, CIC 1408 Vaccinology, 42023 Saint-Etienne, France.

Xavier Roblin (X)

Centre International de Recherche en Infectiologie (CIRI), Team GIMAP, Université de Lyon, Université Claude Bernard Lyon 1, INSERM, U1111, CNRS, UMR530, CIC 1408 Vaccinology, 42023 Saint-Etienne, France.

Gilles Biolley (G)

R&D Laboratory of the Division of Immunology and Allergy, CHUV, Centre des Laboratoires d'Epalinges, 1066 Epalinges, Switzerland.

Blaise Corthésy (B)

R&D Laboratory of the Division of Immunology and Allergy, CHUV, Centre des Laboratoires d'Epalinges, 1066 Epalinges, Switzerland.

Stéphane Paul (S)

Centre International de Recherche en Infectiologie (CIRI), Team GIMAP, Université de Lyon, Université Claude Bernard Lyon 1, INSERM, U1111, CNRS, UMR530, CIC 1408 Vaccinology, 42023 Saint-Etienne, France. Electronic address: stephane.paul@chu-st-etienne.fr.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH